These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 22727545

  • 1. A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
    Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Houdeau E, Théodorou V.
    Clin Nutr; 2013 Feb; 32(1):51-8. PubMed ID: 22727545
    [Abstract] [Full Text] [Related]

  • 2. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.
    Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Lévèque M, Keränen H, Theodorou V, Bourdu-Naturel S, Goupil-Feuillerat N, Legrain-Raspaud S, Eutamene H.
    Neurogastroenterol Motil; 2012 Apr; 24(4):376-e172. PubMed ID: 22272920
    [Abstract] [Full Text] [Related]

  • 3. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M, Guilarte M, Alonso C, Yang P, Martínez C, Ramos L, Lobo B, González A, Guilà M, Pigrau M, Saperas E, Azpiroz F, Santos J.
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [Abstract] [Full Text] [Related]

  • 4. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
    Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Lencina C, Lévêque M, Braniste V, Ménard S, Théodorou V, Houdeau E.
    PLoS One; 2012 Oct; 7(11):e49547. PubMed ID: 23166707
    [Abstract] [Full Text] [Related]

  • 5. Influence of simethicone and alverine on stress-induced alterations of colonic permeability and sensitivity in rats: beneficial effect of their association.
    Bueno L, Beaufrand C, Theodorou V, Andro-Delestrain MC.
    J Pharm Pharmacol; 2013 Apr; 65(4):567-73. PubMed ID: 23488786
    [Abstract] [Full Text] [Related]

  • 6. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC, Brzozowski T, Konturek SJ.
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.
    Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L.
    Gut; 2007 Aug; 56(8):1072-8. PubMed ID: 17309885
    [Abstract] [Full Text] [Related]

  • 8. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B, Klooker TK, Wouters MM, Welting O, van der Loos CM, Stanisor OI, van Diest S, van den Wijngaard RM, Boeckxstaens GE.
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [Abstract] [Full Text] [Related]

  • 9. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L.
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [Abstract] [Full Text] [Related]

  • 10. A protease inhibitor against acute stress-induced visceral hypersensitivity and paracellular permeability in rats.
    Zhao J, Wang J, Dong L, Shi H, Wang Z, Ding H, Shi H, Lu X.
    Eur J Pharmacol; 2011 Mar 11; 654(3):289-94. PubMed ID: 21237151
    [Abstract] [Full Text] [Related]

  • 11. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.
    Am J Gastroenterol; 2013 Aug 11; 108(8):1322-31. PubMed ID: 23711626
    [Abstract] [Full Text] [Related]

  • 12. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.
    Gut; 2008 May 11; 57(5):591-9. PubMed ID: 18194983
    [Abstract] [Full Text] [Related]

  • 13. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M, Alonso C, Guilarte M, Serra J, Martínez C, González-Castro AM, Lobo B, Antolín M, Andreu AL, García-Arumí E, Casellas M, Saperas E, Malagelada JR, Azpiroz F, Santos J.
    Psychoneuroendocrinology; 2012 Jan 11; 37(1):65-77. PubMed ID: 21641728
    [Abstract] [Full Text] [Related]

  • 14. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S, Roeselers G, Levin E, Jonkers DM, Welting O, Heinsbroek SEM, de Weerd HH, Boekhout T, Fornai M, Masclee AA, Schuren FHJ, de Jonge WJ, Seppen J, van den Wijngaard RM.
    Gastroenterology; 2017 Oct 11; 153(4):1026-1039. PubMed ID: 28624575
    [Abstract] [Full Text] [Related]

  • 15. Vagal afferents mediate antinociception of estrogen in a rat model of visceral pain: the involvement of intestinal mucosal mast cells and 5-hydroxytryptamine 3 signaling.
    Yan XJ, Feng CC, Liu Q, Zhang LY, Dong X, Liu ZL, Cao ZJ, Mo JZ, Li Y, Fang JY, Chen SL.
    J Pain; 2014 Feb 11; 15(2):204-17. PubMed ID: 24231720
    [Abstract] [Full Text] [Related]

  • 16. Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment.
    Da Silva S, Robbe-Masselot C, Ait-Belgnaoui A, Mancuso A, Mercade-Loubière M, Salvador-Cartier C, Gillet M, Ferrier L, Loubière P, Dague E, Theodorou V, Mercier-Bonin M.
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug 15; 307(4):G420-9. PubMed ID: 24970779
    [Abstract] [Full Text] [Related]

  • 17. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T, Takeuchi A, Hirata T, Keto Y, Akuzawa S, Sasamata M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):190-5. PubMed ID: 17658508
    [Abstract] [Full Text] [Related]

  • 18. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct 14; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility to stress induced visceral hypersensitivity in maternally separated rats is transferred across generations.
    van den Wijngaard RM, Stanisor OI, van Diest SA, Welting O, Wouters MM, Cailotto C, de Jonge WJ, Boeckxstaens GE.
    Neurogastroenterol Motil; 2013 Dec 14; 25(12):e780-90. PubMed ID: 23965154
    [Abstract] [Full Text] [Related]

  • 20. The multicomponent medication Spascupreel attenuates stress-induced gut dysfunction in rats.
    Theodorou V, Beaufrand C, Yvon S, Laforge G, Burmeister Y, Müller A, Seilheimer B, Bueno L, Eutamene H.
    Neurogastroenterol Motil; 2020 May 14; 32(5):e13798. PubMed ID: 32059072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.